Accelerated axon loss in MOG35-55 experimental autoimmune encephalomyelitis (EAE) in myelin-associated

Melina V Jones1, Thien T Nguyen, Osefame Ewaleifoh

  • 1Johns Hopkins University, Department of Neurology, Room 625, 600N. Wolfe Street, Baltimore 21287, MD, USA.

Insights

Myelin-associated glycoprotein (MAG) protects axons from immune-mediated damage during experimental autoimmune encephalitis (EAE). Loss of MAG accelerates axon loss and increases microglial activation, highlighting its crucial role in neural repair.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Myelin-associated glycoprotein (MAG) is expressed by oligodendrocytes and influences axonal stability and neural repair.
  • MAG inhibits axon extension in lesioned white matter.
  • Previous studies showed increased axon loss in MAG knockout (MAGKO) mice during experimental autoimmune encephalitis (EAE).

Purpose of the Study:

  • To investigate the time course of axon loss in EAE.
  • To confirm the protective role of MAG against immune-mediated axon transection.
  • To explore the relationship between MAG deficiency, microglial activation, and axonal degeneration.

Main Methods:

  • Experimental autoimmune encephalitis (EAE) induction in wild-type and MAG knockout (MAGKO) mice.
  • Assessment of axon loss at different time points post-immunization.
  • Analysis of microglial activation in MAGKO and B4galnt1 knockout (B4galnt1KO) mice.

Main Results:

  • Axon loss in EAE occurs as early as 7 days post-immunization.
  • MAG deficiency exacerbates axon loss in EAE.
  • MAGKO mice show increased microglial activation prior to EAE onset, unlike B4galnt1KO mice.

Conclusions:

  • MAG is protective against immune-mediated axon transection during EAE.
  • Early microglial activation in MAGKO mice may result from the loss of MAG's inhibitory influence, not solely axonal degeneration.

Related Concept Videos